Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -311.44% | -303.06% | -687.18% | -1,724.62% | 296.45% |
| Total Depreciation and Amortization | 115.56% | 43.57% | 122.22% | 68.32% | 46.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.34% | 70.37% | 109.79% | 177.83% | -1,520.67% |
| Change in Net Operating Assets | -4,193.83% | -2,759.87% | -1,199.17% | 78.86% | 769.42% |
| Cash from Operations | -592.12% | -259.57% | -273.50% | -41.43% | -19.30% |
| Capital Expenditure | 95.63% | 80.39% | 37.48% | -5,240.21% | -5,095.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.63% | 80.39% | 37.48% | -206.67% | -151.38% |
| Total Debt Issued | -69.87% | -78.82% | -80.30% | -83.97% | 102.00% |
| Total Debt Repaid | -250.00% | 95.13% | 95.02% | 98.65% | 98.70% |
| Issuance of Common Stock | 66,566.67% | 26,075.26% | 92,603.70% | 331.82% | 240.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 31.24% | -19.71% | -27.57% | -76.02% | 667.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.69% | -169.28% | -132.49% | -112.29% | 3,159.89% |